All In Biotech

Drug Trial Radar · NCT02257723

The Effect of Integrated CAM Treatment in Hospitalized Patients

The Effect of Integrated CAM Treatment in Patients Hospitalized at a Korean Medicine Hospital

Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100,000

Planned (sponsor's estimate)

Start

Jan 2012

Primary completion

Dec 2030

Study completion Dec 2040

Sponsor

Lead sponsor
Jaseng Hospital of Korean MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 6, 2014

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study investigates the effect of hospital-based intensive non-surgical treatment in musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.

Conditions

  • Low Back Pain
  • Neck Pain
  • Knee Pain
  • Shoulder Pain
  • Intervertebral Disc Herniation
  • Spinal Stenosis

Interventions

  • Herbal medicineDrug

    Herbal medicine was taken 3 times daily in dried powder (2g) and water-base decoction form (120ml) (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica).

  • AcupunctureProcedure

    Acupuncture treatment was administered 1-2 times daily using mainly Ah-shi points and local acupuncture points.

  • PharmacopunctureProcedure

    Select ingredients similar to those included in the oral herbal medicine (Ostericum koreanum, Eucommia ulmoides, Acanthopanax Sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica) were freeze dried into powder form after decoction, then diluted in normal saline and adjusted for acidity and pH to be used in injections. The pharmacopuncture injections were injected once daily to the amount of 1 cc and Ah-shi points and local acupuncture points (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • Bee venom pharmacopunctureProcedure

    Bee venom pharmacopuncture was applied after confirming a negative reaction to the hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) was injected at 4-5 acupoints at the physician's discretion. Each acupuncture point was injected with approximately 0.2 cc to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • Chuna manipulationProcedure

    Chuna was administered 3-5 times a week. Chuna is a Korean version of spinal manipulation that incorporates conventional spinal manipulation techniques for mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. NRS of low back pain (LBP)Time frame: Admission (baseline), 2 weeks, Discharge
  2. NRS of radiating leg painTime frame: Admission (baseline), 2 weeks, Discharge
  3. NRS of neck painTime frame: Admission (baseline), 2 weeks, Discharge
  4. NRS of radiating arm painTime frame: Admission (baseline), 2 weeks, Discharge
  5. NRS of knee painTime frame: Admission (baseline), 2 weeks, Discharge
  6. NRS of shoulder painTime frame: Admission (baseline), 2 weeks, Discharge
  7. Oswestry disability index (ODI)Time frame: Admission (baseline), 2 weeks, Discharge
  8. Vernon-Mior Neck Disability Index (NDI)Time frame: Admission (baseline), 2 weeks, Discharge
  9. The Korean Western Ontario McMaster IndexTime frame: Admission (baseline), 2 weeks, Discharge
  10. Shoulder Pain and Disability IndexTime frame: Admission (baseline), 2 weeks, Discharge

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jaseng Hospital of Korean Medicine

    Seoul, Gangnam-Gu, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.